This review summarizes the current investigations that confirm the significance of liver fibrosis (LF) as an independent cardiovascular risk factor in non-alcoholic fatty liver disease (NAFLD ...

On the basis of NAFLD-Fibrosis Score (NAFLD-FS), 13 patients had a low probability of liver fibrosis (F0 to F2), 54 had an indeterminate probability, and 22 a high probability of fibrosis (F3 to F4).

Nonalcoholic fatty liver disease fibrosis scores and Fibrosis-4 index scores increased longitudinally and at a higher rate in those with fatty liver and fibrosis stage 2 or higher compared with ...

This data informed the NAFLD Familial Risk Score, in which a score of at least 4 points corresponded with a 13% or greater risk for NAFLD with advanced fibrosis.

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and can progress to liver cirrhosis, liver failure or cancer. Currently, nonalcoholic steatohepatitis (NASH ...

MAFLD, NAFLD, and the Risk of Peripheral Artery Disease —A study from two large cohorts assessed patients who fit the criteria for metabolic dysfunction–associated fatty liver disease or non ...

Additionally, in the secondary outcomes, we showed that there are surrogates of fatty liver disease including NFS [NAFLD Fibrosis Score], FIB-4, ALT [alanine transaminase], and CAP [controlled ...

Obesity and weight gain were independently associated with an increased risk for fibrosis progression in patients with nonalcoholic fatty liver disease (NAFLD), a study found.

In patients with non-alcoholic fatty liver disease (NAFLD), advanced fibrosis was associated with a greater risk for liver decompensation and all-cause mortality compared to those with lower ...

Dr Jiang recommended that screening for NAFLD in the primary care setting should focus on evaluating the hepatic fibrosis progression in at-risk patients, preferably with non-invasive techniques.